Stay updated on SUSTAIN: Semaglutide vs Sitagliptin in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the SUSTAIN: Semaglutide vs Sitagliptin in Type 2 Diabetes Clinical Trial page.

Latest updates to the SUSTAIN: Semaglutide vs Sitagliptin in Type 2 Diabetes Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedRevision tag on the page was updated from v3.6.5 to v3.6.6. This indicates a minor update to the page's documentation metadata.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedThe site's underlying version was updated from v3.6.4 to v3.6.5, representing a small patch that does not change the study details presented on the page.SummaryDifference0.1%

- Check50 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, indicating a new build deployment. This appears to be an internal update with no described user-facing content changes.SummaryDifference0.0%

- Check71 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3. This indicates a minor maintenance update with no changes to the study details.SummaryDifference0.0%

- Check79 days agoChange DetectedThe page now displays Revision: v3.6.2, replacing the previous v3.6.0. This reflects a site release update rather than modifications to the study content.SummaryDifference0.0%

- Check93 days agoChange DetectedThe page now displays 'No longer looking for participants' and adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study). It also standardizes the Intervention/Treatment label (Intervention/Treatment added vs Intervention / Treatment removed) and updates the revision tag from v3.5.5 to v3.6.0.SummaryDifference0.2%

Stay in the know with updates to SUSTAIN: Semaglutide vs Sitagliptin in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SUSTAIN: Semaglutide vs Sitagliptin in Type 2 Diabetes Clinical Trial page.